Tag: Selumetinib

#VisualAbstract: Addition of selumetinib to radioactive iodine does not improve remission rates in differentiated thyroid cancers

byTeddy Guo

December 20, 2022

Click to read this study in the Journal of Clinical Oncology.

#VisualAbstract: Endocrine therapy plus oral S-1 improves invasive disease-free survival in patients with ER⁺ breast cancer

#VisualAbstract: BRAF/MEK inhibitor therapy may be associated with risk of uveitis in patients with advanced melanoma

byTeddy Guo

February 11, 2021

Click to read the study in the European Journal of Cancer.

Selumetinib increases the uptake of radioiodine in patients with metastatic thyroid cancer refractory to radioiodine

bys25qthea

February 13, 2013

Feb 13th – Published today, 8 out of 20 patients with metastatic thyroid cancer refractory to radioiodine therapy trapped therapeutic ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result